Investor relations
Menu
press releases
01/07/2021
PainReform to Present at the H.C. Wainwright Bioconnect 2021 Conference
01/06/2021
PainReform Announces Appointment of Lotus Clinical Research as CRO for Phase 3 Clinical Trial of PRF-110
01/04/2021
PainReform Appoints Rita Keynan as Vice President of Pharmaceutical Operations
12/03/2020
PainReform Appoints Senior Pharmaceutical Executive and Finance Veteran Ilan Hadar as Chief Executive Officer
11/05/2020
PainReform Welcomes Senior Pharmaceutical Executive and Venture Capitalist Augustine Lawlor to Board of Directors
10/19/2020
